Results 51 to 60 of about 340,102 (305)

Targeted modulation of IGFL2‐AS1 reveals its translational potential in cervical adenocarcinoma

Molecular Oncology, EarlyView.
Cervical adenocarcinoma patients face worse outcomes than squamous cell carcinoma counterparts despite similar treatment. The identification of IGFL2‐AS1's differential expression provides a molecular basis for distinguishing these histotypes, paving the way for personalized therapies and improved survival in vulnerable populations globally.
Ricardo Cesar Cintra, Lucca Paolo Hsu Helmich, Daniel Rodrigues de Bastos, Laura Sichero, Patrícia Savio de Araujo‐Souza, Fabio Passetti, Luisa Lina Villa   +6 more
wiley   +1 more source

Combination of singularly perturbed vector field method and method of directly defining the inverse mapping applied to complex ODE system prostate cancer model

Journal of Biological Dynamics, 2018
We propose a new method to solve a system of complex ordinary differential equations (ODEs) with hidden hierarchy. Given a complex system of the ODE, the hierarchy of the system is generally hidden.
Ophir Nave, Miriam Elbaz
doaj   +1 more source

Species- and organ-specificity of secretory proteins derived from human prostate and seminal vesicles [PDF]

, 1990
Polyclonal antibodies against semenogelin (SG) isolated from human seminal vesicle secretion and acid phosphatase (PAP), β‐microseminoprotein (β‐MSP), and Prostate‐Specific Antigen (PSA) derived from human prostatic fluid, as well as a monoclonal ...
Abrahamsson, P. ‐A,, Aumüller, G.,, Lilja, H.,, Lund University., Scheit, K. ‐H,, Seitz, J.,, Von Kammer, H. Der,   +6 more
core   +2 more sources

KDM7A and KDM1A inhibition suppresses tumour promoting pathways in prostate cancer

Molecular Oncology, EarlyView.
Treatment resistance is a major challenge for patients with advanced prostate cancer. This study examined an alternative approach to target the major prostate cancer‐promoting pathway by targeting epigenetic factors, whose levels are higher in tumours.
Jennie N Jeyapalan, Veronika M Metzler, Simone de Brot, Corinne L Woodcock, Anna E Harris, Jennifer Lothion‐Roy, Emeli M Nilsson, Atara Ntekim, Michael S Toss, Jenny L Persson, Francesca Khani, Brian D Robinson, Lorraine J Gudas, Emad Rakha, David M Heery, Catrin S Rutland, Nigel P Mongan   +16 more
wiley   +1 more source

Terapi Hormonal Primer pada Penderita Kanker Prostat: Evaluasi Survival dan Faktor Prediksinya

Indonesian Journal of Cancer, 2011
Tujuan: Mengevaluasi efektivitas terapi hormonal secaraorchidectomydan medikamentosa sebagai pengobatan primer pada penderita kanker prostat dan faktor prediksi terhadapsurvivalkedua modalitas pengobatan tersebut.
M. Johan, Chaidir Arif Mochtar, Rainy Umbas   +2 more
doaj   +1 more source

Transcriptional profiling of circulating extracellular vesicles from prebiopsy prostate cancer patients

Molecular Oncology, EarlyView.
RNA profiling of circulating extracellular vesicles (EVs) from blood samples of men undergoing prostate biopsy identifies transcripts associated with clinically significant prostate cancer. Integrative analysis with public tumor datasets links EV‐derived gene signatures to tumor stage and progression‐free survival, highlighting CASP3, XRCC2, and RIT1 ...
Stefan Werner, Pierre Tennstedt, Randi C. Pose, Christian Müller, Katharina Besler, Svenja Schneegans, Malik Alawi, Marie C. Roesch, Sven Peine, Desiree Bonci, Joanna Budna‐Tukan, Evi Lianidou, Catherine Alix‐Panabières, Derya Tilki, Klaus Pantel   +14 more
wiley   +1 more source

ROLE OF KINETIC PERFORMANCE OF PSA IN SELECTION OF THE PATIENTS FOR CONDUCTION OF ¹¹C-CHOLINE PET/CT AIMED TO REVEAL LOCAL RECURRENCES OF PROSTATE CANCER

Вестник хирургии имени И.И. Грекова, 2015
Given study was aimed to research a role of kinetic performance of PSA in selection of the patients for conduction ¹¹C-choline PET/CT in order to reveal local recurrences in patient with prostate cancer after radiation therapy (RT) and radical ...
M. A. Rybalov, I. Ya. De Iong, A. I. Breusma, S. Kh. Al’-Shukri, S. Yu. Borovets   +4 more
doaj   +1 more source

Prostate-Specific Antigen: From Promising to Disappointment Tool for Diagnosis of Chronic Renal Failure in Predialysis Patients

Asian Journal of Oncology, 2021
Introduction Prostate-specific antigen (PSA) is a biomarker commonly used for detection of prostate cancer. Its viability as a marker for diagnosis of chronic renal failure (CRF) in predialysis patients was investigated.
Ali Abdul Hussein S Al-Janabi
doaj   +1 more source

On the Age and Binarity of Fomalhaut

, 2012
The nearby (d = 7.7 pc) A3V star Fomalhaut is orbited by a resolved dusty debris disk and a controversial candidate extrasolar planet. The commonly cited age for the system (200+-100 Myr) from Barrado y Navascues et al.
Absil, Baraffe, Barrado y Navascues, Barrado y Navascues, Barrado y Navascués, Busko, Chiang, D'Antona, Dotter, Gliese, Haberreiter, Holland, Janson, Kenworthy, King, Lachaume, Mamajek, Mamajek, Meibom, Perryman, Rhee, Rieke, Serenelli, Shaya, Song, Spiegel, Torres, van Belle, van Leeuwen, Wright, Yi   +30 more
core   +1 more source

Neurophysiological Profile of Antismoking Campaigns [PDF]

, 2018
Over the past few decades, antismoking public service announcements (PSAs) have been used by governments to promote healthy behaviours in citizens, for instance, against drinking before the drive and against smoke.
Aricò, Pietro, Babiloni, Fabio, Cartocci, Giulia, Di Feo, Paolo, Inguscio, Bianca M. S., Mancini, Marco, Modica, Enrica, Perrotta, Davide, Rossi, Dario   +8 more
core   +1 more source